Direkt zum Inhalt
Merck

TNF-α stimulates endothelial palmitic acid transcytosis and promotes insulin resistance.

Scientific reports (2017-03-18)
Wenjing Li, Xiaoyan Yang, Tao Zheng, Shasha Xing, Yaogong Wu, Fang Bian, Guangjie Wu, Ye Li, Juyi Li, Xiangli Bai, Dan Wu, Xiong Jia, Ling Wang, Lin Zhu, Si Jin
ZUSAMMENFASSUNG

Persistent elevation of plasma TNF-α is a marker of low grade systemic inflammation. Palmitic acid (PA) is the most abundant type of saturated fatty acid in human body. PA is bound with albumin in plasma and could not pass through endothelial barrier freely. Albumin-bound PA has to be transported across monolayer endothelial cells through intracellular transcytosis, but not intercellular diffusion. In the present study, we discovered that TNF-α might stimulate PA transcytosis across cardiac microvascular endothelial cells, which further impaired the insulin-stimulated glucose uptake by cardiomyocytes and promoted insulin resistance. In this process, TNF-α-stimulated endothelial autophagy and NF-κB signaling crosstalk with each other and orchestrate the whole event, ultimately result in increased expression of fatty acid transporter protein 4 (FATP4) in endothelial cells and mediate the increased PA transcytosis across microvascular endothelial cells. Hopefully the present study discovered a novel missing link between low grade systemic inflammation and insulin resistance.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
3-Methyladenin, autophagy inhibitor
Sigma-Aldrich
2-Desoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose, ≥97% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human SLC27A4